ETS Variant Transcription Factor 6 Promotes Glucose Metabolism Reprogramming in HCC

Area of Science:

• Oncology
• Molecular Biology
• Metabolic Pathways

Background:

• Glucose metabolic reprogramming is a hallmark of cancer.
• ETV6 is a transcriptional repressor linked to tumorigenesis.
• The role of ETV6 in tumor glucose metabolism is unclear.

Purpose of the Study:

• To investigate the role and mechanism of ETV6 in hepatocellular carcinoma (HCC) glucose metabolism.
• To elucidate the ETV6-miR-429-CRKL regulatory axis in HCC metabolism.

Main Methods:

• In vitro and in vivo studies using ETV6 and CRKL overexpression/knockdown.
• Analysis of miR-429 regulation of glycogen synthesis and degradation.
• Investigation of ETV6 binding to the miR-429 promoter.
• Exploration of the PI3K/AKT pathway involvement.

Main Results:

• ETV6 and CRKL modulate the Warburg effect and glycogen synthesis in HCC.
• miR-429 exhibits opposing effects on the Warburg effect compared to ETV6/CRKL.
• miR-429 enhances glycogen synthesis by regulating GCS and GPa activities.
• ETV6 targets CRKL via miR-429 and the PI3K/AKT pathway to reprogram glucose metabolism.

Conclusions:

• The ETV6-miR-429-CRKL axis is critical for glucose metabolic reprogramming in HCC.
• This regulatory circuitry presents a novel therapeutic target for HCC treatment.